Lijia Luo
Overview
Explore the profile of Lijia Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu X, Wang X, Liao Y, Luo L, Nel A
ACS Nano
. 2025 Mar;
19(9):8579-8594.
PMID: 40025875
We demonstrate reprogramming of the tolerogenic immune environment in the liver for mounting an effective immune response against often-fatal pancreatic cancer metastases. This was achieved by engineering a lipid nanoparticle...
2.
Qiao W, Li J, Luo L, Peng W, Wang X, Jin R, et al.
Ecotoxicol Environ Saf
. 2024 Dec;
289():117436.
PMID: 39637633
Nonalcoholic fatty liver disease (NAFLD) is recognized as a significant public health problem worldwide. Several clinical studies have investigated the associations between Per- and poly-fluoroalkyl substances (PFAS) compounds with the...
3.
Luo L, Fan J, Ma J, Chen W, Song W, Bao S
Ultrasonics
. 2024 Jul;
142:107402.
PMID: 39013349
Bolted joints are widely used in various machines and engineering structures. The tightening state of bolts directly affects the reliability and safety of bolted joints. Therefore, the bolt looseness detection...
4.
Yin F, Wang H, Zhao Z, Luo L, Tang Y, Zhang Y, et al.
Phys Chem Chem Phys
. 2024 Jun;
26(24):17223-17231.
PMID: 38855975
The electronic, optical and photocatalytic properties of GaN/CN van der Waals heterostructures are investigated using the first-principles theory, and effective regulation through element doping or strain is achieved further. The...
5.
Luo L, Wang X, Liao Y, Xu X, Chang C, Nel A
Nano Today
. 2024 Apr;
54.
PMID: 38681872
The prevailing desmoplastic stroma and immunosuppressive microenvironment within pancreatic ductal adenocarcinoma (PDAC) pose substantial challenges to therapeutic intervention. Despite the potential of protein tyrosine kinase (PTK) inhibitors in mitigating the...
6.
Luo L, Wang X, Liao Y, Chang C, Nel A
ACS Nano
. 2023 Jul;
17(15):15216.
PMID: 37504218
No abstract available.
7.
Xu X, Wang X, Liao Y, Luo L, Xia T, Nel A
ACS Nano
. 2023 Feb;
17(5):4942-4957.
PMID: 36853930
While oral desensitization is capable of alleviating peanut allergen anaphylaxis, long-term immune tolerance is the sought-after goal. We developed a liver-targeting lipid nanoparticle (LNP) platform to deliver mRNA-encoded peanut allergen...
8.
Nie F, Zhang L, Cao M, Zhou D, Liu K, Ouyang J, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 Jan;
261(7):1811-1822.
PMID: 36617582
Purpose: To apply propensity score matching to evaluate the impact of peripapillary staphylomas (PPS) on vascular and structural characteristics in the myopic eyes. Methods: This was a prospective, cross-sectional study....
9.
Fang Q, Xu Y, Luo L, Liu C, Li Z, Lin J, et al.
Regen Biomater
. 2022 Aug;
9:rbac036.
PMID: 35936552
The recently emerging bismuth oxyhalide (BiOX) nanomaterials are promising indirect band gap photosensitizer for ultraviolet (UV) light-triggered phototherapy due to their unique layered nanosheet structure. However, the low absorption and...
10.
Luo L, Wang X, Liao Y, Chang C, Nel A
ACS Nano
. 2022 Aug;
16(8):13168-13182.
PMID: 35920660
Although toll-like receptor (TLR) agonists hold great promise as immune modulators for reprogramming the suppressive immune landscape in pancreatic ductal adenocarcinoma (PDAC), their use is limited by poor pharmacokinetics (PK)...